TruBridge Stockholders Approve Acquisition by IKS Health, Merger Expected July 9
TBRG sits 89% above its 52-week low of $13.88.
Summary
TruBridge stockholders approved the company's acquisition by IKS Health, with the merger expected to close on July 9, 2026, leading to the company's delisting.
Key Events · M&A and Partnerships · TBRG
-
Merger Agreement Approved
Stockholders voted overwhelmingly (99.75% of votes cast) in favor of adopting the Agreement and Plan of Merger with Inventurus Knowledge Solutions, Inc. (IKS Health).
-
Executive Compensation Approved
Shareholders also approved, on a non-binding, advisory basis, merger-related compensation for named executive officers.
-
Anticipated Closing & Delisting
The merger is expected to close on July 9, 2026. Upon closing, TruBridge common stock will be delisted from the Nasdaq Global Select Market.
Analysis · TBRG · Technology
TruBridge stockholders have overwhelmingly approved the merger agreement with IKS Health, clearing a major condition for the all-cash acquisition. This vote confirms the transaction is on track to close, with delisting from Nasdaq expected shortly after the anticipated closing date of July 9, 2026. This marks a definitive step towards the company's acquisition and provides certainty for shareholders regarding the $26.25 per share cash payout.
How filings like this one have moved
In the 30 days to Aug 23, 2026, 43.6% of the 999 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.10%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, TBRG was trading at $26.24 on NASDAQ in the Technology sector, with a market capitalization of approximately $393.6M. The 52-week trading range was $13.88 to $26.51. This filing was assessed with neutral market sentiment and an importance score of 9 out of 10.